Cue Biopharma Inc. (CUE)
NASDAQ: CUE
· Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 06:54 PM EDT
Cue Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.48M | -12.26M | -9.5M | -8.66M | -10.17M | -12.35M | -13.43M | -11.01M | -13.19M | -13.11M | -14.59M | -10.96M | -13.21M | -14.26M | -8.38M | -12.99M | -10.28M | -12.51M |
Depreciation & Amortization | 99K | 882K | -238K | 877K | 862K | 849K | 851K | 856K | 849K | 880K | 580.05K | 539K | 384K | 303K | -2.73M | 316K | 314K | 318K |
Stock-Based Compensation | 1.26M | 1.34M | 1.56M | 1.58M | 1.75M | 1.95M | 2.07M | 2.07M | 2.04M | 2M | 2.11M | 2.06M | 2.31M | 3.01M | 2.97M | 3.25M | 2.85M | 2.44M |
Other Working Capital | n/a | -82K | 542K | -2.53M | -2.02M | -990K | -1.63M | 648K | -283K | 226K | 214.89K | 1.12M | -1.34M | -2.81M | -4.62M | -1.63M | -1.59M | -139K |
Other Non-Cash Items | 3.71M | 41K | 45K | -55K | 42K | 42K | 2.99M | 10K | 9K | -109K | -195.78K | -59K | -128K | -71K | -6.44M | 1.15M | 1.13M | 1.12M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.79M | 21K | -41K | n/a | n/a | n/a | n/a | n/a | 3.04M | -2K | -19K | -5K |
Change in Working Capital | n/a | 1.82M | -901K | -1.27M | -2.48M | -274K | -647K | 246K | -40K | -493K | 1.58M | 1.54M | -2.21M | -561K | 895.54K | 1.65M | -3.77M | -3.16M |
Operating Cash Flow | -3.42M | -8.17M | -9.03M | -7.53M | -9.99M | -9.78M | -10.96M | -7.8M | -10.37M | -10.83M | -10.51M | -6.87M | -12.85M | -11.57M | -10.65M | -6.63M | -9.77M | -11.79M |
Capital Expenditures | -27K | -150K | -2K | 1K | -10K | -55K | n/a | n/a | n/a | -2K | -746 | -78K | -65K | -27K | -39 | -13K | -252K | -648K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 205.00 | 3K | 3K | n/a | 10M | 2K | 19K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -149K | -336 | -29.45M | n/a | n/a | 419.00 | n/a | n/a | -5K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 5M | 15M | 5M | 29.44M | n/a | n/a | -10M | n/a | n/a | 10M |
Other Investing Acitivies | n/a | n/a | 1K | 97K | n/a | n/a | n/a | n/a | 5M | 151K | 5M | -29.44M | 3K | n/a | 131.00 | 2K | 19K | 5K |
Investing Cash Flow | -27K | -150K | -1K | 98K | -10K | -55K | n/a | 5M | 5M | 15M | 5M | -29.52M | -62K | -27K | 511.00 | -11K | -233K | 9.35M |
Debt Repayment | n/a | -1M | -999K | -1M | -1M | -1M | -1M | -1M | n/a | n/a | n/a | n/a | n/a | 10M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9K | n/a | -191K | n/a | -482K | n/a | -85K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 17.8M | n/a | 14.24M | n/a | n/a | n/a | n/a | n/a | 85K | 388K | 27.4M | -9K | n/a | -333K | 354.65K | 351K | 309K | 919K |
Financial Cash Flow | 17.8M | -1M | -932K | 9.82M | -1M | 2.35M | 4.78M | 4.59M | 2.1M | 388K | 27.4M | -9K | 11.11M | 15.16M | 7.38M | 351K | 10.67M | 834K |
Net Cash Flow | 14.36M | -9.32M | -9.96M | 2.39M | -11M | -7.49M | -6.18M | 1.79M | -3.27M | 4.56M | 21.89M | -36.4M | -1.8M | 3.56M | -3.26M | -6.29M | 663K | -1.61M |
Free Cash Flow | -3.44M | -8.32M | -9.03M | -7.53M | -10M | -9.84M | -10.96M | -7.8M | -10.37M | -10.84M | -10.51M | -6.95M | -12.91M | -11.6M | -10.65M | -6.64M | -10.02M | -12.44M |